Kansikuva näyttelystä Crying in O.Y.

Crying in O.Y.

Podcast by Zac

englanti

Talous & ura

Rajoitettu tarjous

3 kuukautta hintaan 3,99 €

Sitten 7,99 € / kuukausiPeru milloin tahansa.

  • Podimon podcastit
  • Lataa offline-käyttöön
Aloita nyt

Lisää Crying in O.Y.

Crying in O.Y. | Korean Beauty Retail & Market Intelligence Crying in O.Y. is a structured weekly briefing on what’s changing inside the South Korean beauty industry — and why it matters globally. This is not a product review show. It’s analysis. Each episode breaks down: • M&A activity, IPO signals, and revenue shifts • Retail strategy inside Olive Young and global expansion channels • Margin dynamics, hero-product scaling, and device migration • Cultural drivers that turn local Korean signals into global demand Reporting from Seoul, Crying in O.Y. tracks the structural shifts shaping th

Kaikki jaksot

7 jaksot

jakson APR’s $1B Pivot: From Skincare to Medical Devices kansikuva

APR’s $1B Pivot: From Skincare to Medical Devices

APR has crossed ₩1.5 trillion KRW (over $1B USD) in revenue — and is now expanding beyond skincare into professional-grade medical devices. In this episode of Crying in O.Y., we break down why Medicube’s parent company is moving up the value chain, shifting from mass cosmetics into energy-based clinical equipment. We cover: • How APR doubled revenue year-over-year • Why cosmetics margins eventually compress • The economics of higher ASP through devices • The clinic → home maintenance “treatment loop” • The role of PDRN and longevity positioning • What regulatory approval and hospital adoption will determine next This isn’t product expansion. It’s margin expansion and category repositioning. For professionals in beauty retail, brand strategy, distribution, and aesthetics.

19. helmi 2026 - 6 min
jakson The Mang-gom Effect: Character IP, AOV & Retail Acceleration kansikuva

The Mang-gom Effect: Character IP, AOV & Retail Acceleration

Sorry for the late post—moving house is a full-time job! 📦 In today's episode, your host Zac explores the fascinating world of character collaborations in South Korea. We’re moving beyond the surface-level "cuteness" to look at the hard data: Why do characters like MangGOM drive a 300%–400% increase in web traffic? We analyze the shift from children’s TV icons to "Kidult" culture and how brands like Beplain, Anua, and Numbuzin are using limited-edition merch to clear a quarter’s worth of inventory in just weeks. Key Highlights: * The business of "healing" through IP. * Analysis of Olive Young’s ever-changing Best Seller list. * How character branding helps K-beauty penetrate the US and SE Asian markets. Stay Connected:IG: @cryinginoliveyoungK-Beauty Language Insights: @goojeon.insight

3. helmi 2026 - 10 min
jakson CJ Olive Young’s $20B Wellness Pivot: Inside Olive Better kansikuva

CJ Olive Young’s $20B Wellness Pivot: Inside Olive Better

In this briefing, we dissect the emergence of K-Wellness via the launch of Olive Young's newest platform, Olive Better. We analyze the 2026 F.U.L.L.M.O.O.N. framework and why the industry is pivoting toward "Wholeness" and "Healthy Pleasure." Professional Takeaways: * Beyond Cosmetics: The strategic re-branding of "Health" to "Wellness" as a daily lifestyle practice. * Longevity Economy: How the Gwanghwamun flagship targets high-stress corporate demographics. * The Ingestible Wave: Data supporting the 140-fold increase in inner-beauty film and functional snack consumption. Industry Network: * Visuals: Follow @cryinginoliveyoung on Instagram for updates and more * Global Market News: For insights into how K-Beauty globally, subscribe to @GooJeon—the definitive source for K-Beauty’s international market impact.

30. tammi 2026 - 11 min
jakson Torriden at 100B Won: LG H&H Signals & Indie Consolidation kansikuva

Torriden at 100B Won: LG H&H Signals & Indie Consolidation

Host Zac returns to the "Crying in Olive Young" studio to dissect the success of Torriden, a brand that has mastered the middle ground between "Clean Beauty" and "Dermacosmetics." With the Dive-In Low Molecular Hyaluronic Acid Serum reaching 11 million units sold as of 2025, Torriden isn't just a trend—it's a category leader. We explore the "5-D Complex" technology that makes their HA serum a global bestseller at Sephora and Boots, and why it consistently tops the Olive Young charts. The Business Sidebar: We address the rumors surrounding LG Household & Health Care (LG H&H) and their interest in the indie market. What does CEO Lee Sun-Joo’s "Agile Adaptation" strategy mean for the future of K-Beauty? Plus, we provide an essential update on Dr. Althea’s recent press release regarding their 2026 expansion and internal sale discussions. Key Highlights: * Torriden’s "Your Skin is Our Planet" ethos. * The math behind a 100-billion-won brand. * Hyaluronic Acid: Molecular weights explained. * LG H&H’s shift away from legacy brands toward indie prospects. * Dr. Althea’s 2026 recruitment and growth update. Connect with us:IG: @CryingInOliveYoungKorean Language K-Beauty Updates: @Goojeon

29. tammi 2026 - 9 min
Loistava design ja vihdoin on helppo löytää podcasteja, joista oikeasti tykkää
Loistava design ja vihdoin on helppo löytää podcasteja, joista oikeasti tykkää
Kiva sovellus podcastien kuunteluun, ja sisältö on monipuolista ja kiinnostavaa
Todella kiva äppi, helppo käyttää ja paljon podcasteja, joita en tiennyt ennestään.

Valitse tilauksesi

Suosituimmat

Rajoitettu tarjous

Premium

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

3 kuukautta hintaan 3,99 €
Sitten 7,99 € / kuukausi

Aloita nyt

Premium

20 tuntia äänikirjoja

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

30 vrk ilmainen kokeilu
Sitten 9,99 € / kuukausi

Aloita maksutta

Premium

100 tuntia äänikirjoja

  • Podimon podcastit

  • Ei mainoksia Podimon podcasteissa

  • Peru milloin tahansa

30 vrk ilmainen kokeilu
Sitten 19,99 € / kuukausi

Aloita maksutta

Vain Podimossa

Suosittuja äänikirjoja

Aloita nyt

3 kuukautta hintaan 3,99 €. Sitten 7,99 € / kuukausi. Peru milloin tahansa.